We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
(+14%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$200M |
| 2 |
Amazon
AMZN
|
+$126M |
| 3 |
Deutsche Bank
DB
|
+$109M |
| 4 |
Intuitive Surgical
ISRG
|
+$92.2M |
| 5 |
Wells Fargo
WFC
|
+$83.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$126M |
| 2 |
Abbott
ABT
|
+$79.1M |
| 3 |
VF Corp
VFC
|
+$49M |
| 4 |
JPMorgan Chase
JPM
|
+$48.5M |
| 5 |
BioNTech
BNTX
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.46% |
| 3 | Financials | 11.88% |
| 4 | Communication Services | 9.65% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Chemours
CC
$2.2B
| $1.27M | ﹤0.01% |
37,000
| – | – |
|
852
uniQure
QURE
$3.2B
| $1.27M | ﹤0.01% |
41,300
| – | – |
|
853
Allogene Therapeutics
ALLO
$725M
| $1.26M | ﹤0.01% |
49,900
| – | – |
|
854
Enterprise Products Partners
EPD
$82B
| $1.26M | ﹤0.01% |
+53,000
| New | +$1.25M |
|
855
MongoDB
MDB
$33.5B
| $1.26M | ﹤0.01% |
3,542
-365
| -9% | -$113K |
|
856
Revvity
RVTY
$12.9B
| $1.25M | ﹤0.01% |
8,148
-927
| -10% | -$130K |
|
857
Dana Inc
DAN
$3.21B
| $1.25M | ﹤0.01% |
53,900
| – | – |
|
858
KB Home
KBH
$3.47B
| $1.25M | ﹤0.01% |
30,900
-8,845
| -22% | -$408K |
|
859
Vishay Intertechnology
VSH
$5.08B
| $1.25M | ﹤0.01% |
56,100
| – | – |
|
|
TPTX
860
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.25M | ﹤0.01% |
16,470
| – | – |
|
861
Cousins Properties
CUZ
$4.83B
| $1.24M | ﹤0.01% |
34,318
| – | – |
|
862
EPR Properties
EPR
$4.63B
| $1.24M | ﹤0.01% |
23,954
+3,922
| +20% | +$195K |
|
863
F5
FFIV
$23.2B
| $1.23M | ﹤0.01% |
6,506
-7,656
| -54% | -$1.47M |
|
864
Bath & Body Works
BBWI
$3.89B
| $1.21M | ﹤0.01% |
21,236
+20,275
| +2,110% | +$1.1M |
|
865
Commerce Bancshares
CBSH
$8.41B
| $1.21M | ﹤0.01% |
20,826
| – | – |
|
|
SWTX
866
DELISTED
SpringWorks Therapeutics
SWTX
| $1.21M | ﹤0.01% |
15,250
| – | – |
|
|
ITCI
867
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.21M | ﹤0.01% |
30,900
| – | – |
|
868
Lumen
LUMN
$6.85B
| $1.21M | ﹤0.01% |
+89,088
| New | +$1.23M |
|
869
Halozyme
HALO
$11.6B
| $1.19M | ﹤0.01% |
26,200
| – | – |
|
870
Spotify
SPOT
$105B
| $1.19M | ﹤0.01% |
4,396
-225
| -5% | -$57.1K |
|
|
ALBO
871
DELISTED
Albireo Pharma Inc
ALBO
| $1.19M | ﹤0.01% |
33,900
| – | – |
|
872
Delta Air Lines
DAL
$58.7B
| $1.18M | ﹤0.01% |
27,843
-4,154
| -13% | -$192K |
|
873
Rio Tinto
RIO
$166B
| $1.18M | ﹤0.01% |
14,100
| – | – |
|
|
SAGE
874
DELISTED
Sage Therapeutics
SAGE
| $1.18M | ﹤0.01% |
21,270
| – | – |
|
875
Loews
L
$23.3B
| $1.18M | ﹤0.01% |
21,760
-7,091
| -25% | -$397K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review
As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
- DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
- DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
- DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.